FDA.gov
FDA guidance, safety communications, enforcement materials, recalls, approvals, and the AI-enabled medical-device list.


The medical evidence, scientific literature, and regulatory records Arca searches and cites, from the United States and other jurisdictions.
Your own systems, like Veeva, SharePoint and Slack, are listed under Integrations.
Pick your segment to see the publication indexes, primary records, registries, guidelines, vigilance databases, and regulatory collections Arca searches for teams like yours.
227 sources across 14 collections
Primary U.S. drug, biologic, device, labeling, approval, and regulatory-action records from FDA systems.
18 sources
FDA guidance, safety communications, enforcement materials, recalls, approvals, and the AI-enabled medical-device list.
FDA application and product databases, including Drugs@FDA, 510(k) summaries, PMA, MAUDE, and related records.
Public APIs for drug labels, FAERS and MAUDE events, recalls, device submissions, classifications, and enforcement records.
FDA-hosted prescribing information and product-label search for approved drugs and biological products.
Approved drug products with therapeutic-equivalence evaluations, patents, and exclusivity information.
FDA records for licensed biological products, biosimilars, and interchangeable biosimilar products.
FDA Complete Response Letters describing deficiencies that prevented approval in the submitted form.
Structured product labeling and current SPL records from the National Library of Medicine.
Unique Device Identification records from the Global Unique Device Identification Database.
Full text of FDA warning letters to manufacturers, sponsors, and facilities, indexed by firm, subject, and issuing office.
Form 483 observations released through FDA's FOIA electronic reading room, linked to the inspected establishment.
Inspection outcomes (NAI, VAI, OAI) by establishment, project area, and date from the FDA Data Dashboard.
Shipments refused at the U.S. border with the refusing division, product, firm, and charge codes.
Weekly enforcement-report recalls for drugs, devices, biologics, and food, with recall class, reason, and distribution.
510(k) summaries, PMA summaries of safety and effectiveness (SSEDs), Drugs@FDA review packages, and the AI-enabled device list.
De Novo, HDE, TPLC, product classification, establishment registration & listing, and recognized consensus standards.
Briefing documents, meeting transcripts, and voting outcomes from FDA advisory committee meetings.
Drug shortages, the NDC Directory, the Inactive Ingredient Database, and postmarketing requirements and commitments.
Adverse-event, incident, field-safety-notice, and recall databases for medical devices across the major markets.
15 sources
Used for post-market surveillance, PMCF, and clinical-evaluation vigilance searches.
Manufacturer and User Facility Device Experience reports: medical-device adverse events and malfunctions reported to FDA.
Medical-device recalls and enforcement actions with recall class, product, and root cause.
Canadian medical-device incident reports and recall listings.
UK field safety notices, device safety information, and medical-device alerts.
Swiss medical-device field safety corrective actions and recalls.
German customer information and field corrective actions for medical devices.
French materiovigilance and reactovigilance notices and safety information.
Spanish medical-device safety alerts and field safety notices.
Dutch Health and Youth Care Inspectorate medical-device safety notices.
Irish medical-device safety notices and field safety corrective actions.
Danish Medicines Agency medical-device recalls and safety alerts.
South Korean medical-device recalls and safety notices.
Japanese medical-device recall notices and safety information.
Brazilian medical-device field actions and adverse-event alerts.
Australia's Database of Adverse Event Notifications and System for Australian Recall Actions.
EU MDR and IVDR sources: device registration, notified bodies, coordination-group guidance, harmonised standards, and nomenclature.
8 sources
The European database on medical devices: actor registration, UDI/device records, certificates, and vigilance modules.
Notified body designations and scopes under the MDR and IVDR.
Medical Device Coordination Group guidance on clinical evaluation, PMCF, classification, UDI, and notified-body procedures.
Official Journal listings of harmonised standards and common specifications that give presumption of conformity.
The European Medical Device Nomenclature used for EUDAMED registration and certificate scopes.
Notified-body association position papers, best-practice guides, and code of conduct.
BSI notified-body guidance, technical-documentation expectations, and MDR/IVDR whitepapers.
TÜV SÜD conformity-assessment guidance, certification timelines, and regulatory updates.
Adverse-drug-reaction and vaccine safety databases for signal detection, PSUR/PBRER drafting, and benefit-risk assessment.
8 sources
The FDA Adverse Event Reporting System for drugs and therapeutic biologics, by product, reaction, and outcome.
The U.S. Vaccine Adverse Event Reporting System run by CDC and FDA.
European suspected adverse-drug-reaction reports for centrally and nationally authorised medicines.
Public view of VigiBase, the WHO global database of individual case safety reports.
UK adverse-reaction reports for medicines, vaccines, and medical devices, with interactive drug analysis profiles.
Health Canada's adverse-reaction database for drugs, biologics, and natural health products.
The Netherlands Pharmacovigilance Centre's reports and safety signals.
Australia's adverse-event notifications for medicines and vaccines.
U.S. guidance, regulations, rulemaking records, statutes, and official government publications.
6 sources
Agency guidance documents, compliance policies, rulemaking notices, and regulatory information.
The continuously updated online edition of federal agency regulations, including Title 21.
Proposed and final rules, notices, and presidential documents published by the U.S. government.
Federal rulemaking dockets, supporting materials, notices, and public comments.
Authenticated publications from all three branches of the U.S. federal government.
The official subject-matter codification of the general and permanent laws of the United States.
Biomedical publications and regional literature indexes spanning North America, Europe, Latin America, and global health.
12 sources
Biomedical and life-sciences citations, abstracts, publication types, and controlled vocabulary records.
National Center for Biotechnology Information databases, tools, and integrated life-sciences records.
A full-text archive of biomedical and life-sciences journal literature.
Biomedical publication records, abstracts, citations, grants, and available full text.
WHO-supported global health literature and regional medical indexes.
Latin American and Caribbean health-sciences literature indexed through BIREME/PAHO/WHO.
Regional health-sciences databases and evidence resources from the Virtual Health Library network.
Open-access scholarly journals and collections, including the global and Brazil portals.
Open index of scholarly works, authors, institutions, and citations across every discipline.
Broad scholarly web index for grey literature, theses, and citation discovery.
Elsevier's biomedical and pharmacological database with Emtree indexing, via your institutional subscription.
Elsevier's abstract and citation database, via your institutional subscription.
Trial registrations, status, interventions, outcomes, sponsors, and registry records from the United States, Europe, Asia-Pacific, and Latin America.
14 sources
U.S. and international clinical-study registrations and results through the ClinicalTrials.gov registry.
FDA requirements, guidance, safety communications, and public information related to clinical investigations.
Brazilian Registry of Clinical Trials and a WHO-recognized primary registry.
Cuban Public Registry of Clinical Trials and a WHO-recognized primary registry.
Peru's national registry of authorized clinical trials and related study information.
The Clinical Trials Information System: EU trial applications, decisions, and results under the Clinical Trials Regulation.
Legacy EudraCT protocol and results records for trials started before CTIS.
The International Clinical Trials Registry Platform aggregating primary registries worldwide.
UK-based primary registry for clinical studies across all therapeutic areas.
The German Clinical Trials Register.
The Japan Registry of Clinical Trials.
The Australian New Zealand Clinical Trials Registry.
The Chinese Clinical Trial Registry.
The Clinical Trials Registry – India.
Papers across disciplines, found through the Semantic Scholar Academic Graph and its scholarly datasets.
12 sources
Semantic Scholar documents more than 50 publisher, data-provider, preprint, and crawler inputs. The named source families below reflect its public corpus documentation; additional partner and web-indexed coverage is represented as a combined family.
A multidisciplinary graph of 200M+ papers linking authors, venues, citations, abstracts, external identifiers, and available full text.
DOI-centered scholarly metadata supplied by publishers and registration agencies across journals, proceedings, books, and preprints.
Open preprints spanning physics, mathematics, computer science, quantitative biology, statistics, economics, and related fields.
Preprints across biology, medicine, clinical research, epidemiology, and health sciences before peer review.
Journal, book, conference, and reference literature across the natural sciences, medicine, engineering, and social sciences.
Peer-reviewed journals, reference works, and research across medicine, life sciences, chemistry, engineering, and other disciplines.
Scholarly journals spanning science, technology, medicine, social science, and the humanities.
Peer-reviewed research across health sciences, social science, methods, education, engineering, and related fields.
Computing and information-technology journals, conference proceedings, magazines, and technical publications.
Engineering, computer science, biomedical technology, standards, journals, and conference literature from IEEE and partners.
Open-access location metadata that connects scholarly records to legally available article copies.
Additional publisher feeds, scholarly societies, university presses, repositories, and academic pages discovered through Semantic Scholar's partner network and web crawler.
Public-health guidance, surveillance datasets, epidemiological records, and regional and global health resources.
7 sources
U.S. public-health guidance, disease information, surveillance materials, and health-topic resources.
Public datasets and metadata from the CDC open-data catalog.
Public-health datasets and query tools for mortality, births, disease, and population data.
Global public-health guidance, disease information, reports, standards, and policy resources.
Regional public-health guidance, data, and programs across the Americas.
European Centre for Disease Prevention and Control surveillance data, risk assessments, and public-health guidance.
WHO-supported health literature from regional indexes around the world.
Evidence reviews, clinical recommendations, preventive-service guidance, and health-technology assessments.
5 sources
Healthcare evidence, quality, outcomes, and research resources from the Agency for Healthcare Research and Quality.
Comparative-effectiveness reviews, evidence reports, methods guidance, and stakeholder resources.
Evidence-based clinical preventive-service recommendations from the U.S. Preventive Services Task Force.
Clinical guidance, quality standards, health-technology assessments, and evidence resources.
Systematic reviews, protocols, and controlled-trial evidence from Cochrane's evidence collections.
Pharmacopeial standards and international harmonization, inspection, quality, and medical-device guidance.
17 sources
International Council for Harmonisation quality, safety, efficacy, and multidisciplinary guidelines.
Pharmaceutical Inspection Co-operation Scheme GMP guidance and inspection resources.
United States Pharmacopeia standards, quality resources, and scientific guidance.
Compendial monographs, general chapters, and official United States Pharmacopeia–National Formulary standards.
FDA-hosted regulatory databases and quality-related product records.
ICH guideline documents, implementation status, work products, and supporting materials.
International Medical Device Regulators Forum guidance for medical-device regulatory harmonization.
ISO 13485, 14971, 10993, 14155, and the wider catalogue of quality, risk, and biocompatibility standards.
IEC 60601, 62304, 62366, and other electrical-safety, software-lifecycle, and usability standards.
AAMI standards and technical information reports for device sterilization, software, and quality systems.
ASTM test methods and specifications for materials, packaging, and device performance.
European standardization bodies publishing EN versions of harmonised standards.
The American National Standards Institute catalogue and standards-incorporated-by-reference portal.
European Pharmacopoeia monographs, Certificates of Suitability, and reference standards.
The Global Medical Device Nomenclature used for UDI and regulatory submissions.
ISPE GAMP and Baseline Guides for pharmaceutical engineering, validation, and data integrity.
Parenteral Drug Association technical reports on sterile manufacturing, aseptic processing, and quality.
Coverage decisions and health-technology assessments that determine whether an approved product gets paid for.
10 sources
Medicare National and Local Coverage Determinations, billing codes, and coverage with evidence development.
European joint clinical assessments and joint scientific consultations under Regulation (EU) 2021/2282.
Federal Joint Committee benefit assessments, method evaluations, and reimbursement decisions.
Institute for Quality and Efficiency in Health Care dossier assessments and evidence reports.
Haute Autorité de Santé opinions on medicines and devices, including CNEDiMTS device assessments.
Dutch National Health Care Institute package advice and reimbursement assessments.
Formerly CADTH: reimbursement reviews and health-technology assessments.
Scottish Medicines Consortium advice on the clinical and cost-effectiveness of new medicines for NHSScotland.
Institute for Clinical and Economic Review cost-effectiveness and value assessments.
Pharmaceutical Benefits Advisory Committee outcomes and public summary documents.
Freedom-to-operate, competitor pipelines, and disclosures from patent offices and securities regulators.
5 sources
Patent Public Search, PTAB decisions, and the Patent Center file wrapper.
Full-text search across patents and applications from more than 100 offices.
European Patent Office worldwide patent search and European Patent Register.
International PCT applications and national collections from the World Intellectual Property Organization.
10-K, 10-Q, 8-K, and S-1 filings for competitor pipelines, risk factors, and regulatory disclosures.
Primary medicines, biologics, medical-device, and health-regulatory authorities across global and regional jurisdictions.
90 sources
Global health guidance, norms, standards, prequalification, safety, and regulatory-system resources.
International medical-device regulatory harmonization and shared policy resources.
Federal drug, biologic, medical-device, product-safety, and health-regulatory materials.
Pan-American health and regulatory-harmonization resources for the Americas.
Regional policy, resolutions, and technical regulations for MERCOSUR member states.
Central American economic-integration rules and regional technical-regulation resources.
Argentina's national authority for medicines, food, and medical technology.
Brazil's health-regulatory agency for medicines, biologics, devices, and health products.
Chile's public-health institute and national medicines and medical-device authority.
Colombia's national institute for medicines, food, devices, and sanitary surveillance.
Cuba's national authority for medicines, equipment, and medical devices.
Mexico's federal commission for protection against health risks.
Peru's directorate for medicines, supplies, and drugs.
Ecuador's national agency for regulation, control, and sanitary surveillance.
Bolivia's state agency for medicines and health technologies.
Paraguay's national directorate for sanitary surveillance.
Regional public-health and regulatory-system resources for Caribbean member states.
EU medicines guidance, European Public Assessment Reports (EPARs), EudraVigilance safety information, product records, and authorization materials.
Heads of Medicines Agencies network guidance, and CMDh procedures for mutual-recognition and decentralised authorizations.
EU health policy and legislation, CTIS trial records, and MDR CECP and IVDR PECP expert-panel opinions.
Clinical Evaluation Consultation Procedure (CECP) opinions under the MDR and Performance Evaluation Consultation Procedure (PECP) views under the IVDR.
UK medicines and medical-device policy, licensing, safety, guidance, and enforcement.
Swiss therapeutic-product regulation and the national medical-device database.
France's national agency for the safety of medicines and health products.
German federal regulation of medicines, devices, vaccines, and biomedicines.
Ireland's health-products regulatory authority for medicines, devices, and controlled products.
Italy's medicines agency for authorization, reimbursement, safety, and regulatory policy.
The Dutch medicines evaluation board and national medicine-information resources.
Sweden's Medical Products Agency for medicines and medical devices.
Spain's agency for medicines and health products.
Portugal's national authority for medicines and health products.
Austria's federal office for healthcare safety and medicines oversight.
The Danish Medicines Agency's authorization, safety, reimbursement, and device resources.
Belgium's federal agency for medicines and health products, in English, French, and Dutch.
Poland's office for the registration of medicinal products, medical devices, and biocidal products.
The Czech State Institute for Drug Control's authorizations, safety information, and device oversight.
Slovakia's State Institute for Drug Control for medicines and medical devices.
Hungary's national authority for medicines, medical devices, and pharmacy.
Romania's national agency for medicines and medical devices.
The Bulgarian Drug Agency's authorizations, pharmacovigilance, and medicines registers.
The Greek National Organization for Medicines' authorizations, safety notices, and device oversight.
Croatia's agency for medicinal products and medical devices.
Slovenia's agency for medicinal products and medical devices.
The Finnish Medicines Agency's authorizations, safety information, and medicines guidance.
The Norwegian Medical Products Agency, formerly the Norwegian Medicines Agency, for medicines and medical devices.
Iceland's authority for medicines, medical devices, and pharmacovigilance.
The Estonian State Agency of Medicines' authorizations, safety information, and device oversight.
Latvia's State Agency of Medicines for medicines, medical devices, and pharmacovigilance.
Lithuania's State Medicines Control Agency for authorizations, safety, and medicines registers.
Malta's medicines regulator for authorizations, pharmacovigilance, and inspections.
Ukraine's State Expert Center regulatory, registration, and pharmacovigilance resources.
Uzbekistan's medicines and medical-products safety and regulatory information.
Eurasian Economic Union medicines, medical-device, and technical-regulation materials.
Japanese pharmaceuticals and medical-device review, safety, and regulatory information.
Australian therapeutic-goods regulation, safety updates, guidance, and product information.
China's medicines and medical-device regulator and Center for Drug Evaluation resources.
Korean medicines, biologics, medical-device, safety, and product-information resources.
Taiwan Food and Drug Administration regulatory and product-safety information.
Hong Kong medicine registration, licensing, safety, and pharmaceutical-service resources.
Indian national drug, biologic, device, clinical-trial, and health-policy resources.
Pakistan's drug regulatory authority for therapeutic goods and medical devices.
Bangladesh's directorate for medicine licensing, regulation, and safety.
Sri Lanka's national medicines regulatory authority.
Singapore's regulation of health products, therapeutic products, and medical devices.
Malaysia's pharmaceutical and medical-device regulatory authorities.
Thailand's food, drug, biologic, and medical-device regulatory resources.
Indonesia's authority for drug and food control.
Philippine food, medicine, device, and health-product regulatory resources.
Vietnam's Drug Administration regulatory and product-information resources.
Regional health-product harmonization, standards, and regulatory-cooperation materials.
New Zealand's medicines and medical-device safety authority.
Saudi food, medicine, biologic, and medical-device regulatory resources.
The Emirates Drug Establishment's medical-product regulation and safety resources.
Regional health, procurement, registration, and regulatory-cooperation resources for GCC states.
Egypt's national authority for medicines, biologics, supplies, and medical devices.
Türkiye's medicines and medical-devices agency.
Israeli medicines, medical-device, clinical-trial, and public-health regulatory resources.
Jordan's food and drug administration and medical-product regulatory resources.
Continental medicines-regulatory coordination and harmonization resources.
South Africa's authority for health products, medicines, radiation control, and medical devices.
Nigeria's regulator for food, medicines, medical devices, and other controlled products.
Ghana's food, medicine, medical-device, and health-product regulator.
Ethiopia's authority for medicines, medical devices, food, and health products.
Regional medicines-regulatory harmonization and technical-policy resources.
Kenya's medicines, pharmacy, clinical-trial, and medical-device regulator.
Uganda's national drug authority for medicines and health products.
Tanzania's medicines and medical-devices authority.
Rwanda's food and drugs authority for regulated health products.
Zimbabwe's medicines-control authority and product-safety resources.
The African Vaccine Regulatory Forum's clinical-trial and regulatory-capacity resources.